June 4, 2024

A Short Debrief of My Recent Helicopter Flight, with Conclusions...

Here is a short debrief of my recent helicopter flight over highly C-19 (Covid-19) vaccinated countries:

I observed how the immune escape pandemic is currently causing multi-national flare-ups of C-19 cases in highly C-19 vaccinated populations, against a background of vaccine breakthrough infections and chronic vaccine-associated diseases (long COVID). However, unlike natural viral epidemics or outbreaks, these flare-ups do not allow currently circulating variants to spread sufficiently to sustain viral survival, despite their high intrinsic inter-host transmissibility.

The elephant in the room is that despite all this, nobody wants to consider the virus undergoing a major structural transformation that would enable it to increase its intra-host transmissibility (i.e., multi-organ dissemination within the infected host itself). I have no doubt that, in highly C-19 vaccinated populations, contrary to the expectations of our public health authorities and so-called experts or scientific opinion leaders, the virus will keep knocking on the immune system's door of the vaccinated until it manages to throw that door wide open.

If the population in highly C-19 vaccinated countries does not immediately put more pressure on their governments to halt the virus using safe and efficient antiviral drugs (or even mandating their use!) than they are currently placing on the virus itself, allowing it to become highly virulent, we are undoubtedly heading straight for a dramatic multi-national wave of hyperacute C-19 disease.

There is no greater impotence in all the world like knowing you are right and that the wave of the world is wrong, yet the wave crashes upon you. – Norman Mailer

Support our work
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.


Recent Posts
June 17, 2024

Will there be another newly emerging SARS-CoV-2 variant that outcompetes KP.3 or is this the end of the virus's 'gentle' survival strategy?

June 17, 2024

The Endgame

June 7, 2024

It's going to be a new CoV, not the avian flu virus

Voices for Science and solidarity, © 2023